Daily Anesthesiology Research Analysis
Three studies shape perioperative neuroscience and critical care systems: a mechanistic BJA study links bortezomib neuropathy to blood-nerve barrier dysfunction and identifies netrin-1/cortactin as recovery correlates; an aged-mouse study shows microglia-driven disruption of gamma oscillations underlies perioperative neurocognitive disorder; and a Resuscitation Monte Carlo model finds prehospital ECPR strategies could markedly boost neurologically intact survival in urban OHCA.
Summary
Three studies shape perioperative neuroscience and critical care systems: a mechanistic BJA study links bortezomib neuropathy to blood-nerve barrier dysfunction and identifies netrin-1/cortactin as recovery correlates; an aged-mouse study shows microglia-driven disruption of gamma oscillations underlies perioperative neurocognitive disorder; and a Resuscitation Monte Carlo model finds prehospital ECPR strategies could markedly boost neurologically intact survival in urban OHCA.
Research Themes
- Peripheral neurotoxicity mechanisms and barrier biology in chemotherapy-induced neuropathy
- Microglia–interneuron circuitry and gamma oscillations in perioperative neurocognitive disorder
- Systems modeling to optimize prehospital ECPR delivery in urban out-of-hospital cardiac arrest
Selected Articles
1. Neuronal toxicity and recovery from early bortezomib-induced neuropathy: blood-nerve barrier dysfunction without dorsal root ganglion damage.
In rats, a single bortezomib cycle caused transient tactile/cold allodynia with blood-nerve barrier leakiness and ECM/circadian/immune gene changes in nerve but only modest DRG changes. Recovery resealed the perineurial barrier, normalized axonal morphology and skin innervation, and paralleled cortactin upregulation and netrin-1 increases. In patients with persistent neuropathic pain, skin innervation was reduced and netrin-1 did not increase, implicating barrier remodeling pathways in resolution.
Impact: This translational study reveals barrier biology as a key driver of bortezomib neuropathy and identifies netrin-1/cortactin–linked perineurial sealing as a recovery correlate, opening mechanistically grounded therapeutic avenues.
Clinical Implications: Monitoring small-fiber loss and targeting perineurial barrier repair (e.g., netrin-1 pathways or ECM remodeling) may help prevent or reverse chemotherapy-induced neuropathy; anesthesiologists and pain specialists could incorporate barrier-protective strategies alongside dose management.
Key Findings
- Early bortezomib produced transient tactile and cold allodynia in rats with perineurial small-molecule leakiness that resealed during recovery.
- Nerve transcriptomics highlighted circadian, extracellular matrix, and immune gene regulation; DRG changes were modest.
- Cortactin expression in perineurium and netrin-1 levels increased with pain resolution; patients with persistent pain showed reduced skin innervation without netrin-1 increase.
Methodological Strengths
- Multisystem translational approach (rat behavior, barrier assays, transcriptomics, IHC, and patient skin data).
- Concordant structural-functional readouts linking barrier integrity, molecular markers (cortactin, netrin-1), and behavioral outcomes.
Limitations
- Human data were correlative and limited in sample depth; causal validation in patients is lacking.
- Temporal window focused on early toxicity; long-term remodeling and dosing regimens were not evaluated.
Future Directions: Test barrier-sealing biologics (e.g., netrin-1 agonism) and ECM-modulatory strategies in preclinical models and early-phase trials; develop biomarkers of perineurial leakiness for patient stratification.
BACKGROUND: The use of the first in class proteasome inhibitor bortezomib (BTZ) is highly effective in the treatment of multiple myeloma. However, its long-term use is limited by the fact that most treated patients develop painful polyneuropathy. In some of the treated patients, pain resolves with time; in others, it persists, with the underlying mechanisms poorly understood. One prerequisite for neural toxicity is the ability of a drug to penetrate the blood-nerve barrier. METHODS: Here, we analysed the pathways involved in early BTZ-induced polyneuropathy development and its resolution in rats and in myeloma patients using pain behaviour, barrier analysis, transcriptomics, immunohistochemistry, and clinical data. RESULTS: One cycle of BTZ elicited transient tactile and cold allodynia in rats. Transcriptomic signature and network analysis revealed regulation of circadian, extracellular matrix, and immune genes within the nerve and modest changes in the dorsal root ganglia. Recovery processes resealed the small molecule leakiness of the perineurial barrier, reversed axonal swelling, and normalised fibre density in the skin. Expression of the microtubule-associated cytoskeletal protein cortactin matched this process in the perineurium. Netrin-1 as a known barrier sealer was also upregulated in pain resolution in nerve and skin. In patients with painful BTZ-induced polyneuropathy, skin innervation was reduced and netrin-1 was unchanged, compatible with the persistence of pain. CONCLUSIONS: In summary, our data demonstrate that early bortezomib toxicity targets mainly peripheral nerves and indicate that pain resolution could be supported by protective growth factors such as netrin-1 for remodelling of the extracellular matrix and neuronal barriers. CLINICAL TRIAL REGISTRATION: DRKS00025422.
2. Optimizing extracorporeal cardiopulmonary resuscitation delivery for out-of-hospital cardiac arrest: a Monte Carlo simulation study.
Using geospatial Monte Carlo simulations of Montreal OHCA, prehospital ECPR strategies outperformed in-hospital models, increasing CPC 1–2 survival to 39.5–42.0%, achieving 99.7–100% flow recovery at 60 minutes, and reducing low-flow times by 7.8–12 minutes. Expanding in-hospital centers yielded modest gains, while a rendezvous model was intermediate.
Impact: This systems-level analysis quantifies the potential survival benefit of deploying mobile ECPR teams, informing urban EMS design and resource allocation for maximum neurological outcomes.
Clinical Implications: Urban EMS systems considering ECPR should prioritize prehospital deployment models to minimize low-flow time and improve neurologically intact survival; planning must address staffing, training, and logistics for mobile ECMO teams.
Key Findings
- Prehospital ECPR strategies achieved the highest modeled CPC 1–2 survival (39.5–42.0%) and 60-minute flow recovery (99.7–100%).
- Low-flow time was substantially reduced with prehospital teams (−7.8 to −12 minutes) versus in-hospital strategies.
- Increasing in-hospital ECPR centers from 2 to 4 yielded only modest improvements (CPC 1–2: 25.3% to 28.0%).
Methodological Strengths
- Large-scale Monte Carlo simulation with 2000 iterations grounded in real OHCA geospatial and operational data.
- Machine-learning–derived transport time estimates and comparison of multiple deployment strategies.
Limitations
- Simulation-based outcomes may not capture real-world implementation barriers (team availability, cannulation times, patient selection).
- Single-EMS urban setting limits generalizability; no cost-effectiveness analysis included.
Future Directions: Prospective pragmatic trials or stepped-wedge implementations comparing in-hospital versus prehospital ECPR, with cost, safety, and equity outcomes; refine criteria integrating real-time prediction.
BACKGROUND: Extracorporeal cardiopulmonary resuscitation (ECPR) can improve outcomes in refractory out-of-hospital cardiac arrest (OHCA), but access is limited by geographic and system constraints. We aimed to compare the potential impact of different ECPR delivery strategies in an urban setting using simulation modeling. METHODS: We performed a Monte Carlo simulation using historical OHCA data (2015-2019) from Montreal's sole EMS. Each of 2000 iterations simulated 1240 annual OHCA cases using geospatial heatmaps. Patients meeting ECPR criteria (witnessed arrest, bystander CPR, age ≤ 70 years old) were included. We tested in-hospital models (2-, 3-, and 4-hospital), a rendezvous model, and two prehospital strategies: hospital-based deployment and an optimally located mobile team. Transport times were estimated using a machine learning model trained on real operational data. Outcomes included survival with favorable neurological outcome, proportion of patients achieving flow recovery at 60 min and low-flow time. RESULTS: On average, 255 patients were included per iteration. With in-hospital ECPR delivery, increasing from 2 to 4 hospitals modestly improved CPC 1-2 survival (25.3% vs 28.0%), flow recovery at 60 min (69.2% vs 75.1%), and low-flow interval (-2.4 min. Rendezvous yielded 28.8% CPC 1-2 survival, 77.3% flow-recovery at 60 min and -2.9 min low-flow time. Prehospital strategies had the greatest impact, improving CPC 1-2 survival (39.5% and 42.0%), flow-recovery at 60 min (99.7% and 100%), and low-flow time (-7.8 and -12 min) for hospital-based and optimally placed teams respectively. CONCLUSION: In this simulation, prehospital ECPR strategies showed the potential to increase survival, improve flow recovery at 60 min, and reduce low-flow times in urban OHCA.
3. Gamma Oscillation Disruption Induced By Microglial Activation Contributes to Perioperative Neurocognitive Disorders in Aged Mice.
In aged mice undergoing exploratory laparotomy, hippocampal microglia became activated, proinflammatory cytokines increased, PV interneuron markers (PV, GAD67) decreased, and gamma oscillations were disrupted, yielding hippocampus-dependent cognitive deficits. Microglial depletion (PLX3397) or inhibition (minocycline) restored PV/GAD67 expression, improved gamma oscillations, and rescued cognition.
Impact: This work mechanistically links microglial activation to cortical network dysfunction (gamma oscillations) and identifies actionable targets (microglia, PV interneuron preservation) for PND mitigation.
Clinical Implications: Perioperative neuroinflammation is a modifiable driver of PND; anti-inflammatory microglial modulators and interventions preserving PV interneuron function warrant clinical exploration in older surgical patients.
Key Findings
- Exploratory laparotomy in aged mice activated hippocampal microglia and increased TNF-α, IL-1β, and IL-6, causing hippocampus-dependent cognitive deficits.
- PV and GAD67 expression decreased with disrupted gamma oscillations; microglial depletion restored PV/GAD67 and normalized gamma rhythms.
- Perioperative minocycline improved cognition, supporting microglia-targeted strategies for PND.
Methodological Strengths
- Use of aged mice with behavioral assays (CFC, MWM), molecular profiling, and electrophysiological readouts.
- Pharmacologic manipulations (PLX3397, minocycline) to test causality of microglial activation.
Limitations
- Findings are preclinical; translational relevance to human PND requires validation.
- Timing and dosing paradigms for microglial modulation were limited to perioperative windows.
Future Directions: Pilot trials testing microglia-targeted anti-inflammatories and gamma-modulating interventions in older surgical patients; biomarker development (EEG gamma, cytokines) for risk stratification.
Perioperative neurocognitive disorder (PND) is a prevalent postoperative complication of the central nervous system (CNS) in elderly patients. Advanced age is an independent risk factor for developing PND. Microglia are essential immune cells in the CNS and play a critical role in neuroinflammation. The activation of microglia is closely linked to PND, although the precise mechanism remains unclear. Gamma oscillations (30-100 Hz) are associated with higher cognitive functions, including attention. The aim of this study was to investigate the mechanism by which microglial activation in PND disrupts gamma oscillations. The study utilized 18-month-old male C57BL/6 J mice and established a PND model through exploratory laparotomy. The results of both Contextual Fear Conditioning (CFC) and Morris Water Maze (MWM) experiments demonstrated that exploratory laparotomy could lead to hippocampus-dependent neurocognitive dysfunction in aged mice. We observed that exploratory laparotomy induced the transformation of microglia in the hippocampus of aged mice into an activated phenotype characterized by enlarged cell bodies and shortened processes. This transformation was accompanied by a significant increase in the expression levels of pro-inflammatory factors in hippocampal tissue, including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6). Specific depletion of microglia in aged mice, achieved by drinking water supplemented with the colony-stimulating factor 1 receptor (CSF1R)/c-Kit kinase inhibitor PLX3397 for seven consecutive days, resulted in a reduction of postoperative hippocampal neuroinflammation and a significant improvement in cognitive dysfunction. Similarly, perioperative inhibition of microglial activation with minocycline resulted in cognitive improvement. Additionally, we found that the expression levels of hippocampal parvalbumin (PV) and glutamate decarboxylase 67 (GAD67) were significantly reduced following exploratory laparotomy, which was accompanied by disturbed gamma oscillations. Depletion of microglia restored the expression levels of PV and GAD67 and significantly improved the disturbances in gamma oscillations. These findings suggest that the activation of hippocampal microglia and the associated neuroinflammatory response following surgery play a crucial role in PND. The underlying mechanism may be related to disturbed gamma oscillations and a reduction in the inhibitory function of PV interneurons.